Alzheimer's disease and dementia are progressive neurological conditions impacting memory, cognitive abilities, and behavior. Alzheimer's, the most prevalent form of dementia, is characterized by the accumulation of beta-amyloid plaques and tau protein tangles in the brain, resulting in the gradual deterioration of neurons and brain tissue. Symptoms typically begin with mild memory impairment and worsen over time, significantly affecting daily functioning.
Neuropsychological assessments are pivotal in diagnosing Alzheimer's and dementia, evaluating various cognitive domains like memory, attention, language, and problem-solving skills. These tests provide critical insights into the extent and progression of cognitive decline, aiding clinicians in treatment planning and monitoring. They play a crucial role in distinguishing Alzheimer's from other forms of dementia and in tracking cognitive changes longitudinally. Early detection through these assessments facilitates timely interventions and support, enhancing patient care and management strategies for individuals and their families.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States